Author:
Movahedi Mohammad,Hepworth Elliot,Mirza Reza,Cesta Angela,Larche Maggie,Bombardier Claire
Funder
CIHR
Ontario Ministry of Health and Long-Term Care
Canadian Arthritis Network
CAN
Amgen
Merck
Novartis
Subject
Anesthesiology and Pain Medicine,Rheumatology
Reference25 articles.
1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update;Smolen;Ann Rheum Dis,2017
2. Widdifield J, Paterson JM, Bernatsky S, Tu K, Tomlinson G, Kuriya B, et al. The epidemiology of rheumatoid arthritis in Ontario, Canada. Arthritis Rheumatol 2014. p. 786–93.
3. Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet 2017. p. 2338–48.
4. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs;Bykerk;J Rheumatol,2012
5. American College of Rheumatology guideline for the treatment of rheumatoid arthritis;Singh;Arthritis Rheumatol,2015